טוען...
Usefulness of mycophenolate mofetil in Indian patients with C3 glomerulopathy
BACKGROUND: C3 glomerulopathy (C3G) is a heterogeneous disease caused by alternative complement pathway abnormalities without any standardized treatment. An immunosuppressive agent, mycophenolate mofetil (MMF), has been recently shown to be useful in treating C3G, mainly in studies from the west. We...
שמור ב:
| הוצא לאור ב: | Clin Kidney J |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6671524/ https://ncbi.nlm.nih.gov/pubmed/31384438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfy127 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|